TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: faecal consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: disruption of normal activities scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: prevalence of medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MCA velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cerebrovascular outcomes
Primary endpoint: mycobactericidal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline CST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eyes with resolved edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete sensory anesthesia by 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep disturbances postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Ability to perform usual activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in malaria incidences
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in resting density of mosquitoes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: motor recovery after stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge about schizophrenia
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient and doctor behaviour in shared decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician-Administered PTSD Scale (CAPS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiologic responders during script-driven imagery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Need for pharmacologic hemodynamic support with epinephrine
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in DH (Dental Hypersensitivity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily activity score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to resolve fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute neutrophil count (ANC) above 500 cells per microliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma HIV-1 RNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: NAA/Cr ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: in hospital mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Six-week survival
Endpoint domain: Mortality/survival
Primary endpoint: Attention capacity at 20 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial responses and stable diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic certainty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral density at the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bone mineral content (BMC) at the femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Defibrillation threshold voltage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stored energy at defibrillation threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sustained abstinence from smoking at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of video epochs rated as ON without troublesome dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate or severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: poor or unbearable tolerance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unwillingness to undergo colonoscopy again
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of low disease activity achievement according to SDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ulcer area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ulcer depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of clinically relevant symptoms of functional dyspepsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentration of immunoreactive nonfunctional form of DHFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentration of active DHFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: TLC (Total Lymphocyte Count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of adhesion reformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decrease in exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increase in forced expiratory volume in 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: High-density lipoprotein (HDL) cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastroparesis cardinal severity index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fasting tachygastria ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postprandial/fasting bradygastria ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lp-PLA(2) mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lp-PLA(2) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in modified Bishop score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abnormal fetal heart rate patterns
Endpoint domain: Adverse events/effects
Primary endpoint: acute postoperative swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to monitor performance and implement strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kansas City Cardiomyopathy Questionnaire overall score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NRS score changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOMI score changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major adverse cardiac event (MACE) rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Angiographic restenosis rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Normalized neointimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total mean costs of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response rate of cervical lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Tolerance to radiotherapy and chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse reactions (neutropenia, anemia, gastrointestinal reactions, oral mucositis, radiation dermatitis)
Endpoint domain: Adverse events/effects
Primary endpoint: TDI olfactory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Complex Regional Pain Syndrome Type 1 symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in Pi(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvements in Pe(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvements in RLP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: risk of at least one grade ≥3 adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: postprandial glycemia measured by 2 h glucose area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SPPB score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of target diagnoses captured
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median SOI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: axillary and chest wall drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of axilla seromas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospitalization stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mean marginal bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: first episodes of clinically diagnosed pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: survival rates at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: plasma CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RT-PCR-confirmed influenza attack rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sCD14 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hsCRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lp-PLA2 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Epworth Sleepiness Score (ESS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Quality of life tests: PSQI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life tests: SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychosocial aspects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to enter clinical trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in overall CPRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MADRAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of hospitalizations for asthma attacks
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Basal insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholesterol level control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetes control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Skeletal and soft tissue changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to active labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemodynamic benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequate relief of FD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agitation disruptiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription of psychotropic medication
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of intraoperative hemodynamic instability
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of postoperative pulmonary embolism
Endpoint domain: Adverse events/effects
Primary endpoint: Pulmonary leukocyte sequestration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dynamic lung compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: A‐aO2 gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maternal side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Median duration of local control
Endpoint domain: Mortality/survival
Primary endpoint: Rates of surgical treatment by sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: DNR/comfort care decisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction with personal program progress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initiation and continuation of behaviour change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular pigment optical density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: letter contrast sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: propofol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: institutional cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CAS prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MVP prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agreement between MVP and CAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of exercise for chronic low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of exercise for fibromyalgia syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular Pressure (IOP) difference between Tono-Pen and Icare PRO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAFLD activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from AF at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percentage of patients discontinuing treatment due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Ticagrelor 24-hour area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-hour PRU values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LTA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with clinically relevant DDIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cfmDNA levels at week 32
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cftDNA levels at week 32
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cffDNA levels during mid-pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in post-operative pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Apoptosis rate of tumor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mean daily symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of symptom free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of fertility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dropout from ADM
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: fractional flow reserve (FFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: major adverse cardiovascular events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of fall of serum total bilirubin (STB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of failure of phototherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extent of wall motion asynergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improved performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Five-kilometer run time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight at three month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in drinking and associated problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cholesterol risk management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: perceived weight status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of steam pop
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative altered sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of topical ketoprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prolonged fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Increased β‐glucosidase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decreased colonic pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proliferation of Bacteroides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average bioequivalence of clarithromycin ER to IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and frequency of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary protein/creatinine ratio reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: DPD activity in tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma uracil levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed microbiologic growth
Endpoint domain: Adverse events/effects
Primary endpoint: Isolation of gram-positive bacteria
Endpoint domain: Adverse events/effects
Primary endpoint: Susceptibility to vancomycin
Endpoint domain: Adverse events/effects
Primary endpoint: esophageal eosinophil count reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: validated endoscopic severity score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: validated histologic grade and stage score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum glutamine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lactulose/mannitol ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CD4/CD8-positive T-lymphocyte ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dry eye scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flare scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved main symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ideal stool consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: upset by ED therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Infectious and non-infectious wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: safety of the quadrivalent vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of the quadrivalent vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes